We are live on ! Find out more
ASPX

AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX

Delisted

ASPX was delisted on the 4th of May, 2015.

Back to rankings

138 hedge funds and large institutions have $1.91B invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2015 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 41 increasing their positions, 20 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

704% more call options, than puts

Call options by funds: $14.8M | Put options by funds: $1.85M

233% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 21

147% more capital invested

Capital invested by funds: $773M → $1.91B (+$1.14B)

105% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 20

80% more funds holding in top 10

Funds holding in top 10: 5 → 9 (+4)

55% more funds holding

Funds holding: 89 → 138 (+49)

Holders
138
Holders Change
+49
Holders Change %
+55.06%
% of All Funds
3.68%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.24%
New
70
Increased
41
Reduced
20
Closed
21
Calls
$14.8M
Puts
$1.85M
Net Calls
+$13M
Net Calls Change
+$13M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$99.9M
2
JHIU
Janus Henderson Investors US
Colorado
+$41.7M
3
AAM
Alpine Associates Management
Florida
+$38.8M
4
WIC
Water Island Capital
New York
+$33.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$30M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$152M
2
Jennison Associates
Jennison Associates
New York
-$29.4M
3
KCM
Kingdon Capital Management
New York
-$21.1M
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$20M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$7.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
ALPS Advisors
Colorado
$1.52M +$1.01M +15,173 New
HA
77
Havens Advisors
New York
$1.51M +$999K +15,000 New
WMSA
78
Weiss Multi-Strategy Advisers
New York
$1.5M +$333K +5,000 +50%
KAM
79
Kassirer Asset Management
Ontario, Canada
$1.5M +$999K +15,000 New
AllianceBernstein
80
AllianceBernstein
Tennessee
$1.44M +$813K +12,200 +555%
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
$1.44M +$959K +14,400 New
Citigroup
82
Citigroup
New York
$1.33M +$278K +4,166 +46%
WAM
83
Wolverine Asset Management
Illinois
$1.25M +$833K +12,500 New
TAM
84
Tocqueville Asset Management
New York
$1.22M +$96.6K +1,450 +14%
SG Americas Securities
85
SG Americas Securities
New York
$1.22M +$578K +8,681 +251%
GC
86
Guggenheim Capital
Illinois
$1.18M +$781K +11,727 New
HHC
87
Hutchin Hill Capital
New York
$1.05M +$696K +10,451 New
PAMP
88
Polar Asset Management Partners
Ontario, Canada
$1M +$666K +10,000 New
RhumbLine Advisers
89
RhumbLine Advisers
Massachusetts
$992K +$219K +3,285 +50%
HCM
90
Harvey Capital Management
Florida
$977K +$226K +3,400 +54%
BC
91
Birchview Capital
Vermont
$902K -$1.1M -16,500 -65%
NFA
92
Nationwide Fund Advisors
Ohio
$884K +$12.2K +183 +2%
Connor, Clark & Lunn Investment Management (CC&L)
93
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$832K -$6.66K -100 -1%
MLICM
94
Metropolitan Life Insurance Company (MetLife)
New York
$807K – – –
OAM
95
Orinda Asset Management
California
$802K +$533K +8,000 New
AC
96
Andromeda Capital
New York
$769K +$511K +7,674 New
UBS AM
97
UBS AM
Illinois
$702K +$466K +7,000 New
NSEDCP
98
NJ State Employees Deferred Compensation Plan
New Jersey
$662K – – –
Group One Trading
99
Group One Trading
Illinois
$652K +$433K +6,500 New
OC
100
Oppenheimer & Co
New York
$602K +$400K +6,000 New
2 3
4
5 6

ASPX Hedge Fund Activity: Q1 2015 in Review

138 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q1 2015, worth a combined $1.91B — up 147% from $773M a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new ASPX positions and 21 closed out — a net gain of 49 holders — while 41 added to existing stakes and 20 trimmed.

The largest buyer was Deerfield Management, adding an estimated $99.9M. The largest seller was Fidelity Investments, cutting an estimated $152M.

  • 138 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q1 2015, up from 89 in Q4 2014.
  • Funds reported $1.91B of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q1 2015, up 147% quarter-over-quarter.
  • 70 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q1 2015 and 21 closed out, a net change of +49 holders.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2015 was Deerfield Management, an estimated $99.9M added.
  • The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q1 2015 was Fidelity Investments, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2015.